Over time this blockage can lead to heart attack, while severe blockages in multiple major vessels may require coronary artery bypass graft surgery.
What does CABGS stand for?
CABGS stands for Coronary Artery Bypass Graft Surgery
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Carotid Artery Blood Flow Velocity
- Carotid Artery Blood Flow Waveform
- Cardiac Artery Bypass Graft (less common)
- Clone Army Builders Guild (modeling club)
- Concanavalin A-Binding Glycoprotein (internal medicine)
- Coronary Angioplasty Bypass Grafting (cardiology)
- Coronary Aorta Bypass Grafting (cardiovascular medicine)
- Coronary Artery Bypass Graft (cardiology)
- Chip Array Ball Grid Array
- Cabinda Gulf Oil Company Ltd
- Central Animal Breeding House (University of Queensland; Australia)
- Consumers Association in Bosnia and Herzegovina (Sarajevo, Bosnia and Herzegovina)
- Conventional-direction Asymmetric Branch-line Hybrid (microwave integrated circuit)
- Committee on Agricultural Biotechnology, Health, and the Environment
- Center for Applied Behavioral Health Policy (Phoenix, AZ)
- Center for Addiction and Behavioral Health Research (University of Wisconsin-Milwaukee)
- Child and Adolescent Behavioral Health Services (Minnesota)
- Consumer Assessment of Behavioral Health Services
- California Birth Index
- Canadian Association of Business Incubation (Toronto, Ontario, Canada)
Samples in periodicals archive:
OBJECTIVE: Coronary artery bypass graft surgery remains associated with significant postoperative cardiovascular morbidity and mortality in high-risk patients.
Thirty patients scheduled for elective coronary artery bypass graft surgery were randomly assigned to receive 150-180 mg per day of coenzyme Q10 (CoQ10) or no CoQ10 (control group) for 7 to 10 days preoperatively.
Appendix The following additional information is provided in accordance with the Code of Best Practice for Reporting by Life Science Companies: A Randomized, Double-blind, Placebo-controlled study of Glypromate(R) in Patients undergoing Coronary Artery Bypass Graft Surgery Protocol Abbreviated Name: Studying Neurons Using Glypromate (SNUG) Name of Investigational Agent: Glypromate(R) (glycyl-L-prolyl-L-glutamate) Study Centres: 4 centres in New Zealand, 1 in Australia Phase of Development: 2a Objectives: Primary: To investigate the pharmacokinetics of Glypromate(R) in post-CABG patients Secondary: To monitor the safety profile of Glypromate(R) treatment compared to placebo in CABG patients.
The program's highlight is a live broadcast of a low-risk coronary artery bypass graft surgery.
Patients in New York state who undergo coronary artery bypass graft surgery and are covered by either private managed-care or Medicare managed-care insurance are significantly less likely than patients with fee-for-service insurance to have the surgery done in hospitals with lower mortality rates, according to a study published in The Journal of the American Medical Association.